OTCM
CEOS
Market cap1mUSD
Aug 21, Last price
0.01USD
1D
13.14%
1Q
-23.51%
Jan 2017
-42.87%
IPO
-98.08%
Name
CeCors Inc
Chart & performance
P/E
0.58
P/S
—
EPS
0.01
Div yield, %
—
Shrs. gr., 5y
10.28%
Rev. gr., 5y
206.78%
Revenues
0
-100.00%
Net income
3m
P
CFO
1m
-50.70%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
CeCors, Inc. engages in the acquisition and development of healthcare companies focusing on military veterans. It operates through the PsyKey and VETCOMM segments. The PsyKey segment refers to consumer goods. It is related to the sales of coffee products. The VETCOMM segment includes recurring services such as education and resources. The company was founded on April 16, 2002 and is headquartered in Toronto, Canada.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||